Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

McLeod syndrome: Five new pedigrees with novel mutations.

Weaver J, Sarva H, Barone D, Bobker S, Bushara K, Hiller A, Ishii M, Jankovic J, Lakhani S, Niotis K, Scharre DW, Tuite P, Stutz A, Westhoff CM, Walker RH.

Parkinsonism Relat Disord. 2019 Jul;64:293-299. doi: 10.1016/j.parkreldis.2019.04.022. Epub 2019 May 2.

PMID:
31103486
2.

Cognitive self-assessment scales in surgical settings: Acceptability and feasibility.

Stoicea N, Koehler KN, Scharre DW, Bergese SD.

Best Pract Res Clin Anaesthesiol. 2018 Sep - Dec;32(3-4):303-309. doi: 10.1016/j.bpa.2018.08.001. Epub 2018 Aug 9. Review.

PMID:
30522721
3.

Alpha-synuclein mRNA isoform formation and translation affected by polymorphism in the human SNCA 3'UTR.

Barrie ES, Lee SH, Frater JT, Kataki M, Scharre DW, Sadee W.

Mol Genet Genomic Med. 2018 May 6. doi: 10.1002/mgg3.407. [Epub ahead of print]

4.

Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease.

Scharre DW, Weichart E, Nielson D, Zhang J, Agrawal P, Sederberg PB, Knopp MV, Rezai AR; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2018;62(2):621-633. doi: 10.3233/JAD-170082.

PMID:
29400666
5.

Computational integration of nanoscale physical biomarkers and cognitive assessments for Alzheimer's disease diagnosis and prognosis.

Yue T, Jia X, Petrosino J, Sun L, Fan Z, Fine J, Davis R, Galster S, Kuret J, Scharre DW, Zhang M.

Sci Adv. 2017 Jul 28;3(7):e1700669. doi: 10.1126/sciadv.1700669. eCollection 2017 Jul.

6.

Digitally translated Self-Administered Gerocognitive Examination (eSAGE): relationship with its validated paper version, neuropsychological evaluations, and clinical assessments.

Scharre DW, Chang SI, Nagaraja HN, Vrettos NE, Bornstein RA.

Alzheimers Res Ther. 2017 Jun 27;9(1):44. doi: 10.1186/s13195-017-0269-3.

7.

Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease.

Fritz NE, Kegelmeyer DA, Kloos AD, Linder S, Park A, Kataki M, Adeli A, Agrawal P, Scharre DW, Kostyk SK.

Gait Posture. 2016 Oct;50:1-7. doi: 10.1016/j.gaitpost.2016.08.009. Epub 2016 Aug 11.

PMID:
27544062
8.

Gene expression profiling of brain samples from patients with Lewy body dementia.

Pietrzak M, Papp A, Curtis A, Handelman SK, Kataki M, Scharre DW, Rempala G, Sadee W.

Biochem Biophys Res Commun. 2016 Oct 28;479(4):875-880. doi: 10.1016/j.bbrc.2016.09.114. Epub 2016 Sep 22.

9.

Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.

Scharre DW, Chang SI, Nagaraja HN, Park A, Adeli A, Agrawal P, Kloos A, Kegelmeyer D, Linder S, Fritz N, Kostyk SK, Kataki M.

J Alzheimers Dis. 2016 Oct 4;54(3):995-1004.

PMID:
27567844
10.

Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.

Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, De La Gandara JE, Agronin M, Davis CS, Nguyen U, Shin P, Tariot PN, Siffert J.

JAMA. 2015 Sep 22-29;314(12):1242-54. doi: 10.1001/jama.2015.10214.

PMID:
26393847
11.

Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood-brain links in Alzheimer's disease.

Naughton BJ, Duncan FJ, Murrey DA, Meadows AS, Newsom DE, Stoicea N, White P, Scharre DW, Mccarty DM, Fu H.

J Alzheimers Dis. 2015;43(1):93-108. doi: 10.3233/JAD-140606.

12.

Community Cognitive Screening Using the Self-Administered Gerocognitive Examination (SAGE).

Scharre DW, Chang SI, Nagaraja HN, Yager-Schweller J, Murden RA.

J Neuropsychiatry Clin Neurosci. 2014 Fall;26(4):369-75. doi: 10.1176/appi.neuropsych.13060145.

PMID:
24419587
13.

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.

Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM; Alzheimer's Disease Neuroimaging Initiative; Pediatric Imaging, Neurocognition, and Genetics Study, Weiner M, Aisen P, Petersen R, Jack CR Jr, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Mathis C, Cairns NJ, Taylor-Reinwald L, Trojanowki JQ, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Foroud TM, Potkin S, Shen L, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Quinn J, Lind B, Dolen S, Schneider LS, Pawluczyk S, Spann BM, Brewer J, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Ances B, Carroll M, Leon S, Mintun MA, Schneider S, Marson D, Griffith R, Clark D, Grossman H, Mitsis E, Romirowsky A, deToledo-Morrell L, Shah RC, Duara R, Varon D, Roberts P, Albert M, Onyike C, Kielb S, Rusinek H, de Leon MJ, Glodzik L, De Santi S, Doraiswamy PM, Petrella JR, Coleman RE, Arnold SE, Karlawish JH, Wolk D, Smith CD, Jicha G, Hardy P, Lopez OL, Oakley M, Simpson DM, Porsteinsson AP, Goldstein BS, Martin K, Makino KM, Ismail MS, Brand C, Mulnard RA, Thai G, Mc-Adams-Ortiz C, Womack K, Mathews D, Quiceno M, Diaz-Arrastia R, King R, Weiner M, Martin-Cook K, DeVous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Swerdlow RH, Apostolova L, Lu PH, Bartzokis G, Silverman DH, Graff-Radford NR, Parfitt F, Johnson H, Farlow MR, Hake AM, Matthews BR, Herring S, van Dyck CH, Carson RE, MacAvoy MG, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Ging-Yuek, Hsiung R, Feldman H, Mudge B, Assaly M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Mesulam MM, Lipowski K, Wu CK, Johnson N, Sadowsky C, Martinez W, Villena T, Turner RS, Johnson K, Reynolds B, Sperling RA, Johnson KA, Marshall G, Frey M, Yesavage J, Taylor JL, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Kowall N, Killiany R, Budson AE, Norbash A, Johnson PL, Obisesan TO, Wolday S, Bwayo SK, Lerner A, Hudson L, Ogrocki P, Fletcher E, Carmichael O, Olichney J, Kittur S, Borrie M, Lee TY, Bartha R, Johnson S, Asthana S, Carlsson CM, Potkin SG, Preda A, Nguyen D, Tariot P, Fleisher A, Reeder S, Bates V, Capote H, Rainka M, Scharre DW, Kataki M, Zimmerman EA, Celmins D, Brown AD, Pearlson GD, Blank K, Anderson K, Santulli RB, Schwartz ES, Sink KM, Williamson JD, Garg P, Watkins F, Ott BR, Querfurth H, Tremont G, Salloway S, Malloy P, Correia S, Rosen HJ, Miller BL, Mintzer J, Longmire CF, Spicer K, Finger E, Rachinsky I, Drost D, Jernigan T, McCabe C, Grant E, Ernst T, Kuperman J, Chung Y, Murray S, Bloss C, Darst B, Pritchett L, Saito A, Amaral D, DiNino M, Eyngorina B, Sowell E, Houston S, Soderberg L, Kaufmann W, van Zijl P, Rizzo-Busack H, Javid M, Mehta N, Ruberry E, Powers A, Rosen B, Gebhard N, Manigan H, Frazier J, Kennedy D, Yakutis L, Hill M, Gruen J, Bosson-Heenan J, Carlson H.

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3985-90. doi: 10.1073/pnas.1105829109. Epub 2012 Feb 16.

14.

Normal pressure hydrocephalus: measure twice, shunt once.

Scharre DW.

Neurology. 2011 Sep 20;77(12):1110-1. doi: 10.1212/WNL.0b013e31822f0335. Epub 2011 Aug 17. No abstract available.

PMID:
21849649
15.

Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study.

Scharre DW, Vekeman F, Lefebvre P, Mody-Patel N, Kahler KH, Duh MS.

Drugs Aging. 2010 Nov 1;27(11):903-13. doi: 10.2165/11584290-000000000-00000.

PMID:
20964464
16.

Self-administered Gerocognitive Examination (SAGE): a brief cognitive assessment Instrument for mild cognitive impairment (MCI) and early dementia.

Scharre DW, Chang SI, Murden RA, Lamb J, Beversdorf DQ, Kataki M, Nagaraja HN, Bornstein RA.

Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):64-71. doi: 10.1097/WAD.0b013e3181b03277.

PMID:
20220323
17.

Allelic mRNA expression of sortilin-1 (SORL1) mRNA in Alzheimer's autopsy brain tissues.

Alachkar H, Kataki M, Scharre DW, Papp A, Sadee W.

Neurosci Lett. 2008 Dec 19;448(1):120-4. doi: 10.1016/j.neulet.2008.10.034. Epub 2008 Oct 15.

18.

One-week dose titration of extended release galantamine in patients with Alzheimer's disease.

Scharre DW, Shiovitz T, Zhu Y, Amatniek J.

Alzheimers Dement. 2008 Jan;4(1):30-7. doi: 10.1016/j.jalz.2007.10.013. Epub 2007 Dec 21.

PMID:
18631948
19.

Problem solving ability in patients with mild cognitive impairment.

Beversdorf DQ, Ferguson JL, Hillier A, Sharma UK, Nagaraja HN, Bornstein RA, Scharre DW.

Cogn Behav Neurol. 2007 Mar;20(1):44-7.

PMID:
17356344
20.

Defining and diagnosing involuntary emotional expression disorder.

Cummings JL, Arciniegas DB, Brooks BR, Herndon RM, Lauterbach EC, Pioro EP, Robinson RG, Scharre DW, Schiffer RB, Weintraub D.

CNS Spectr. 2006 Jun;11(S6):1-7.

PMID:
16816786
21.

Blipped multi gradient-echo slice excitation profile imaging (bmGESEPI) for fast T2 * measurements with macroscopic B0 inhomogeneity compensation.

Truong TK, Chakeres DW, Scharre DW, Beversdorf DQ, Schmalbrock P.

Magn Reson Med. 2006 Jun;55(6):1390-5.

22.

Effects of static and radiofrequency magnetic field inhomogeneity in ultra-high field magnetic resonance imaging.

Truong TK, Chakeres DW, Beversdorf DQ, Scharre DW, Schmalbrock P.

Magn Reson Imaging. 2006 Feb;24(2):103-12. Epub 2005 Dec 27.

PMID:
16455399
23.

High-resolution 8 Tesla imaging of the formalin-fixed normal human hippocampus.

Chakeres DW, Whitaker CD, Dashner RA, Scharre DW, Beversdorf DQ, Raychaudhury A, Schmalbrock P.

Clin Anat. 2005 Mar;18(2):88-91.

PMID:
15696533
24.

Donepezil in the treatment of dementia with lewy bodies.

Beversdorf DQ, Warner JL, Davis RA, Sharma UK, Nagaraja HN, Scharre DW.

Am J Geriatr Psychiatry. 2004 Sep-Oct;12(5):542-4. No abstract available.

PMID:
15353396
25.

A pilot open-label trial of citalopram for restless activity and aberrant motor behaviors in Alzheimer disease.

Scharre DW, Davis RA, Warner JL, Chang SI, Beversdorf DQ.

Am J Geriatr Psychiatry. 2003 Nov-Dec;11(6):687-91.

PMID:
14609811
26.

Combination therapy of donepezil and vitamin E in Alzheimer disease.

Klatte ET, Scharre DW, Nagaraja HN, Davis RA, Beversdorf DQ.

Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):113-6.

PMID:
12794389
27.

Cognitive and behavioral effects of quetiapine in Alzheimer disease patients.

Scharre DW, Chang SI.

Alzheimer Dis Assoc Disord. 2002 Apr-Jun;16(2):128-30.

PMID:
12040309
28.

Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria.

Mega MS, Masterman DL, Benson DF, Vinters HV, Tomiyasu U, Craig AH, Foti DJ, Kaufer D, Scharre DW, Fairbanks L, Cummings JL.

Neurology. 1996 Dec;47(6):1403-9.

PMID:
8960718
29.

Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease.

Munroe WA, Southwick PC, Chang L, Scharre DW, Echols CL Jr, Fu PC, Whaley JM, Wolfert RL.

Ann Clin Lab Sci. 1995 May-Jun;25(3):207-17.

PMID:
7605102
30.

Parkinson's disease: making the diagnosis, selecting drug therapies.

Scharre DW, Mahler ME.

Geriatrics. 1994 Oct;49(10):14-6, 20-3.

PMID:
7926845
31.

Visual agnosia and optic aphasia: are they anatomically distinct?

Schnider A, Benson DF, Scharre DW.

Cortex. 1994 Sep;30(3):445-57.

PMID:
7805385
32.

Shaken baby syndrome.

Spaide RF, Swengel RM, Scharre DW, Mein CE.

Am Fam Physician. 1990 Apr;41(4):1145-52. Review.

PMID:
2181831
33.

HIV and acute onset of psychosis.

Maccario M, Scharre DW.

Lancet. 1987 Aug 8;2(8554):342. No abstract available.

PMID:
2886809

Supplemental Content

Loading ...
Support Center